Image_3_The Imbalance of Circulating Follicular Helper T Cells and Follicular Regulatory T Cells Is Associated With Disease Activity in Patients With Ulcerative Colitis.TIF
Ulcerative colitis (UC) is a chronic inflammatory bowel disease affecting the colon and rectum, in which the abnormality of B cells is involved in both its pathogenesis and progression. Follicular helper T cells (TFH) play an important role in assisting the immune function of human B cells in germinal centers, and follicular regulatory T cells (TFR) have the function of inhibiting TFH and germinal center B cell responses. The significance of circulating TFH and TFR in ulcerative colitis (UC) remains unclear. We analyzed peripheral blood of active and stable remission UC patients and found that circulating TFR was significantly decreased while TFH was increased in active UC patients. As to TFH subsets, TFH2 was elevated while TFH17 was decreased in active UC, with IL-4/IL-17A secretion enhanced. Helios+ and CD45RA−FoxP3high TFR cells were decreased while CD226+ and CD45RA+FoxP3int TFR cells were increased in active UC patients. The levels of new memory B cells, plasmablasts and serum IgG were significantly increased in active UC patients, and were positively correlated with TFH and TFH2, and negatively correlated with TFR. Serum CRP and Mayo Clinic scores were positively correlated with TFH and TFH2 but negatively correlated with TFR. Serum IL-12 and IL-21 were up-regulated while IL-10 was down-regulated in active UC. To conclude, an imbalance of circulating TFH and TFR cells is associated with disease activity in UC patients. Our results suggest a new mechanism for TFH and TFR imbalance in the pathogenesis of UC, providing a new perspective for theoretical research and therapeutic strategies for UC.
History
References
- https://doi.org//10.1053/j.gastro.2019.01.002
- https://doi.org//10.1159/000368447
- https://doi.org//10.1016/S0140-6736(16)32126-2
- https://doi.org//10.1016/j.advms.2016.09.001
- https://doi.org//10.1093/ibd/izy395
- https://doi.org//10.1007/s00428-005-0136-7
- https://doi.org//10.1111/jcmm.12728
- https://doi.org//10.3389/fimmu.2018.01884
- https://doi.org//10.1007/s10875-016-0268-3
- https://doi.org//10.1016/j.it.2015.05.005
- https://doi.org//10.1590/1414-431x20165209
- https://doi.org//10.1016/j.coi.2016.08.003
- https://doi.org//10.1002/art.39020
- https://doi.org//10.12659/MSM.914868
- https://doi.org//10.3892/mmr.2014.2824
- https://doi.org//10.1042/CS20171258
- https://doi.org//10.1097/MD.0000000000014757
- https://doi.org//10.3389/fimmu.2018.01536
- https://doi.org//10.1186/s13075-018-1690-0
- https://doi.org//10.1084/jem.20170901
- https://doi.org//10.3389/fimmu.2018.01761
- https://doi.org//10.1016/j.intimp.2018.01.038
- https://doi.org//10.1002/art.40430
- https://doi.org//10.1136/gut.2010.224154
- https://doi.org//10.1056/NEJM198712243172603
- https://doi.org//10.1097/MIB.0000000000000223
- https://doi.org//10.4049/jimmunol.1201379
- https://doi.org//10.1371/journal.pone.0034547
- https://doi.org//10.1172/JCI81187
- https://doi.org//10.4049/jimmunol.1402381
- https://doi.org//10.1016/j.immuni.2009.03.019
- https://doi.org//10.1016/j.jaci.2015.08.027
- https://doi.org//10.1016/j.immuni.2008.05.009
- https://doi.org//10.1038/icb.2009.64
- https://doi.org//10.4049/jimmunol.1001657
- https://doi.org//10.1002/eji.201847862
- https://doi.org//10.1038/ni.2496
- https://doi.org//10.1016/j.immuni.2014.12.006
Usage metrics
Read the peer-reviewed publication
Categories
- Transplantation Immunology
- Tumour Immunology
- Immunology not elsewhere classified
- Immunology
- Veterinary Immunology
- Animal Immunology
- Genetic Immunology
- Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)
- Autoimmunity
- Cellular Immunology
- Humoural Immunology and Immunochemistry
- Immunogenetics (incl. Genetic Immunology)
- Innate Immunity